Form 4: Hims & Hers Health, Inc.: Chief Legal Officer Acquires Restricted Stock Units
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., acquired 193,584 Restricted Stock Units (RSUs) on February 28, 2024, according to a Form 4 filing with the SEC.
Summary
- On February 28, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., was granted 193,584 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs are subject to a 4-year service-based vesting requirement, with vesting occurring in substantially equal quarterly installments on March 15, June 15, September 15, and December 15, starting June 15, 2024.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Positives
- The acquisition of RSUs by a key executive aligns their interests with those of the shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of RSUs by a key executive can positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction: Soleil Boughton acquired Restricted Stock Units. |
| 03/01/2024 | Date of Form 4 filing. |
| 06/15/2024 | First Company Quarterly Vesting Date for the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.